You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Locally advanced or metastatic urothelial carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma Trial in Philadelphia (Enfortumab

Not yet recruiting
  • Urothelial Carcinoma
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center - Philadelphia
Jun 27, 2023

Urothelial Carcinoma Trial in Shanghai (BL-B01D1, SI-B003)

Not yet recruiting
  • Urothelial Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 27, 2023

Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Solid Tumor Trial (TYRA-300)

Not yet recruiting
  • Locally Advanced Urothelial Carcinoma
  • +3 more
  • (no location specified)
Sep 15, 2022

HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

Not yet recruiting
  • Urothelial Carcinoma
    • (no location specified)
    Jun 5, 2023

    Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

    Recruiting
    • Locally Advanced Bladder Urothelial Carcinoma
    • +13 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Jun 8, 2022

    Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

    Not yet recruiting
    • Locally Advanced Bladder Urothelial Carcinoma
    • +31 more
    • Diagnostic Laboratory Biomarker Analysis
    • Nivolumab
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Advanced Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma Trial in Sacramento

    Recruiting
    • Advanced Urothelial Carcinoma
    • +3 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Jun 28, 2022

    Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation, Locally Advanced Urothelial Carcinoma, Metastatic

    Recruiting
    • Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation
    • +3 more
    • Cabozantinib S-malate
    • +3 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Aug 8, 2022

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +41 more
    • Ipilimumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 11, 2022

    Urothelial Carcinoma Trial in Shanghai (AZD4547, Tislelizumab)

    Recruiting
    • Urothelial Carcinoma
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Mar 8, 2023

    Urothelial Carcinoma Trial (disitamab vedotin, pembrolizumab, gemcitabine)

    Not yet recruiting
    • Urothelial Carcinoma
    • disitamab vedotin
    • +4 more
    • (no location specified)
    Jun 9, 2023

    Melanoma, Urothelial Carcinoma, Renal Cell Carcinoma Trial in Auchenflower (RC198 Injection)

    Not yet recruiting
    • Melanoma
    • +5 more
    • RC198 Injection
    • Auchenflower, Queensland, Australia
      Research Site
    May 17, 2023

    Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in

    Recruiting
    • Advanced Bladder Urothelial Carcinoma
    • +23 more
    • Riverside, California
    • +8 more
    Jul 16, 2022

    Urothelial Carcinoma Trial in France (Talazoparib + Avelumab)

    Recruiting
    • Urothelial Carcinoma
    • Talazoparib + Avelumab
    • Angers, France
    • +13 more
    Aug 9, 2022

    Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

    Recruiting
    • Locally Advanced Bladder Urothelial Carcinoma
    • +18 more
    • Los Angeles, California
    • +2 more
    Jun 28, 2022

    Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter Urothelial Carcinoma, Locally Advanced Urethral

    Recruiting
    • Locally Advanced Renal Pelvis Urothelial Carcinoma
    • +20 more
    • Duarte, California
    • +16 more
    Aug 10, 2022

    Carcinoma, Transitional Cell, HER-2 Gene Amplification Trial in Beijing (Trastuzumab)

    Recruiting
    • Carcinoma, Transitional Cell
    • HER-2 Gene Amplification
    • Beijing, China
      National Cancer Center/Cancer Hospital, Chinese Academy of Medic
    Mar 31, 2022

    Urothelial Carcinoma Trial in Worldwide (Zilovertamab vedotin)

    Recruiting
    • Urothelial Carcinoma
    • Zilovertamab vedotin
    • Cleveland, Ohio
    • +11 more
    Jan 25, 2023

    Learn About First-line Avelumab Maintenance in Japanese Locally

    Not yet recruiting
    • Urothelial Carcinoma
    • Nagoya, Aichi, Japan
    • +14 more
    Jul 21, 2022

    Urothelial Carcinoma Trial in Irvine, Dallas, Houston (MRx0518, Avelumab 20 mg/mL Intravenous Solution (IV))

    Active, not recruiting
    • Urothelial Carcinoma
    • MRx0518
    • Avelumab 20 mg/mL Intravenous Solution (IV)
    • Irvine, California
    • +2 more
    Jul 5, 2022

    Locally Advanced or Metastatic Solid Tumors, NSCLC, HNSCC Trial in Australia, United States (RO7502175, Atezolizumab)

    Recruiting
    • Locally Advanced or Metastatic Solid Tumors
    • +10 more
    • Aurora, Colorado
    • +6 more
    Jan 4, 2023

    Urothelial Carcinoma, HER2-expressing Trial in Beijing (RC48-ADC, Toripalimab, Gemcitabine)

    Not yet recruiting
    • Urothelial Carcinoma
    • HER2-expressing
    • Beijing, Beijing, China
    • +1 more
    Apr 2, 2022

    Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

    Recruiting
    • Urothelial Carcinoma
    • +20 more
    • Gilbert, Arizona
    • +9 more
    Feb 3, 2022

    Locally Advanced or Metastatic Urothelial Carcinoma Trial in United States (Avelumab, Sacituzumab Govitecan, M6223)

    Recruiting
    • Locally Advanced or Metastatic Urothelial Carcinoma
    • Coeur d'Alene, Idaho
    • +19 more
    Oct 4, 2022

    Urothelial Carcinoma Trial in China (RC48-ADC)

    Active, not recruiting
    • Urothelial Carcinoma
    • Hefei, Anhui, China
    • +7 more
    Feb 20, 2022